Company
Awakn Lifesciences
Solvonis Therapeutics plc (LSE: SVNS) is an emerging biopharmaceutical company developing novel medicines for high-burden CNS disorders.
Also known as Solvonis Therapeutics
- Status
- Operatingas of 2026-09-20
- Business model
- B2B
- Legal name
- Solvonis Therapeutics
- awaknlifesciences.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- Press page (opens in a new tab)
Claim, correct or request removal
Record updated 28 September 2026
About
At Solvonis, we are developing novel therapeutics to address these challenges and bring new hope to patients. Our initial focus is on Alcohol Use Disorder (AUD) and Post-Traumatic Stress Disorder (PTSD), while our discovery programmes support expansion across Addiction and Psychiatry and evaluate a future entry point into Neurology.
Funding snapshot
- Latest round
- Undisclosed2026-08-25
Funding rounds
- Round, 2026
- 2026-08-25
Loading relationship preview